Apo-Sildenafil

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Sildenafil citrate 28.1mg equivalent to sildenafil 20mg

Disponible depuis:

Apotex NZ Ltd

DCI (Dénomination commune internationale):

Sildenafil citrate 28.1 mg (equivalent to sildenafil 20mg)

Dosage:

20 mg

forme pharmaceutique:

Film coated tablet

Composition:

Active: Sildenafil citrate 28.1mg equivalent to sildenafil 20mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Hyprolose Hypromellose Macrogol 8000 Magnesium stearate Microcrystalline cellulose Titanium dioxide

Unités en paquet:

Blister pack, Al/PVC, 90 tablets

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

Signa SA de CV

indications thérapeutiques:

APO-SILDENAFIL 20 mg is used to treat patients with symptom-limited pulmonary arterial hypertension (Group I of the WHO classification of pulmonary hypertension) to improve exercise capacity. The efficacy of APO-SILDENAFIL has not been evaluated in patients currently on bosentan therapy.

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, Al/PVC - 90 tablets - 36 months from date of manufacture stored at or below 30°C - Bottle, plastic, HDPE with blue cap and induction seal - 90 tablets - 36 months from date of manufacture stored at or below 30°C

Date de l'autorisation:

2011-08-10